Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 8Polycystic Ovary Syndrome 5Multiple Myeloma 5Prostatic Neoplasms 4Neoplasm Metastasis 3Colorectal Neoplasms 3Stomach Neoplasms 2Small Cell Lung Carcinoma 2Pancreatic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Venous Thromboembolism 1Urinary Bladder Neoplasms 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Thrombosis 1Smoldering Multiple Myeloma 1Sarcoma, Ewing 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Rectal Neoplasms 1Perioperative Inflammatory Response 1Ovarian Neoplasms 1Osteosarcoma 1Neurotoxicity Syndromes 1

Interventions

Propranolol 2daratumumab 1Watchful Waiting 1Surgical Procedures, Operative 1Simvastatin 1Observation 1DNA 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemangioma, Cavernous, Central Nervous System × Simvastatin × Clear all
NCT01764451 2024-03-12

Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins

University of New Mexico

Phase EARLY_PHASE1 Terminated
12 enrolled
CNS

Hemangioma, Cavernous, Central Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon âš¡